Lonza Group Ltd (LZAGF PINK) stock market data APIs
$794.3771
1.84(0.2%)
as of November 13, 2026
Try our APIs with
free plan!
Lonza Group Ltd Financial Data Overview
Price chart is built with
Anychart
Lonza Group AG, together with its subsidiaries, operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Integrated Biologics; Advanced Synthesis; and Specialized Modalities segments. The Integrated Biologics segment offers CDMO biologics services from clinical development, drug substance, and drug product manufacturing; and operates mammalian and drug product platforms. Its Advanced Synthesis segment manufactures antibody-drug conjugates (ADCs) and other bioconjugates, small molecules, and highly potent active pharmaceutical ingredients; and operates small molecules and bioconjugates platforms. The Specialized Modalities segment operates various technologies, such as spanning cell & gene, microbial, bioscience, and mRNA. Lonza Group AG was incorporated in 1897 and is headquartered in Basel, Switzerland.
Prev. Close
794.3771
Open
796.2218
High
797.4521
Low
793.7996
52 wk Range
557.5439-841.45
Market Cap
55 646 M
P/E Ratio
41.9101
Shares Outstanding
69 844 K
Revenue
6 871 M
EPS
1.8923
Dividends (Yield)
0.0062
Beta
0.802
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Lonza Group Ltd (top by weight)
Ticker
100-day Price Change
Weight
MSSIX.US
VICTORY TRIVALENT INTERNATIONAL SMALL-CAP FUND (FORMERLY VICTORY MUNDER INTERNATIONAL SMALL-CAP FUND) CLASS R6
-1.3
(-5.8%)
1.12
MCISX.US
VICTORY TRIVALENT INTERNATIONAL SMALL-CAP FUND (FORMERLY VICTORY MUNDER INTERNATIONAL SMALL-CAP FUND) CLASS C
-1.3
(-6.09%)
1.12
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Lonza Group Ltd data using free add-ons & libraries
Get Lonza Group Ltd Fundamental Data
Lonza Group Ltd Fundamental data includes:
- Net Revenue: 6 871 M
- EBITDA: 2 390 M
- Earnings Per Share: 19
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2021-06-30
- EPS/Forecast: 0
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Lonza Group Ltd News
New
Lonza (SWX:LONN) Stock Could Be 15% Overvalued On Its US CDMO Deal
Lonza Group has delivered a strong share-price run in recent years, and fresh deal activity is adding a new layer to the story. The question now is whether the current valuation can be supported by th...
Merck exits U.S. CDMO operations in sale to Lonza
Merck KGaA (MKGAF [https://seekingalpha.com/symbol/MKGAF]) has agreed to sell five U.S. contract development and manufacturing (CDMO) sites to Swiss drug manufacturer Lonza (LZAGY [https://seekingalph...
Lonza raises mid-term margin goal, says Q3 in line with expectations
Investing.com -- Swiss drugmaker services group Lonza raised its mid-term profitability goal on Wednesday, targeting a core EBITDA margin in the high thirties, and said third-quarter performance was i...
Gene Transfer Technologies Market Size, Share & Trends Analysis to 2036 Featuring Profiles of Thermo Fisher Scientific, Lonza Group, Oxford Biomedica, FUJIFILM Diosynth Biotechnologies, Aldevron and More
Company Logo Dublin, Sept. 23, 2026 (GLOBE NEWSWIRE) -- "Gene Transfer Technologies Market Size, Share & Trends Analysis - Global Opportunity Analysis and Industry Forecast (2026-2036)" has been adde...
Get Lonza Group Ltd fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.